» Articles » PMID: 28831207

Intrathecal Resiniferatoxin Modulates TRPV1 in DRG Neurons and Reduces TNF-Induced Pain-Related Behavior

Overview
Publisher Wiley
Specialties Biochemistry
Pathology
Date 2017 Aug 24
PMID 28831207
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Transient receptor potential vanilloid-1 (TRPV1) is a nonselective cation channel, predominantly expressed in sensory neurons. TRPV1 is known to play an important role in the pathogenesis of inflammatory and neuropathic pain states. Previous studies suggest interactions between tumor necrosis factor- (TNF-) alpha and TRPV1, resulting in a modulation of ion channel function and protein expression in sensory neurons. We examined the effect of intrathecal administration of the ultrapotent TRPV1 agonist resiniferatoxin (RTX) on TNF-induced pain-associated behavior of rats using von Frey and hot plate behavioral testing. Intrathecal injection of TNF induces mechanical allodynia (2 and 20 ng/kg) and thermal hyperalgesia (200 ng) 24 h after administration. The additional intrathecal administration of RTX (1.9 g/kg) alleviates TNF-induced mechanical allodynia and thermal hyperalgesia 24 h after injection. In addition, TNF increases the TRPV1 protein level and number of TRPV1-expressing neurons. Both effects could be abolished by the administration of RTX. These results suggest that the involvement of TRPV1 in TNF-induced pain offers new TRPV1-based experimental therapeutic approaches and demonstrates the analgesic potential of RTX in inflammatory pain diseases.

Citing Articles

Neurotoxins Acting on TRPV1-Building a Molecular Template for the Study of Pain and Thermal Dysfunctions.

Beignon F, Notais M, Diochot S, Baron A, Fajloun Z, Tricoire-Leignel H Toxins (Basel). 2025; 17(2).

PMID: 39998081 PMC: 11861614. DOI: 10.3390/toxins17020064.


Electroacupuncture Alleviates Streptozotocin-Induced Diabetic Neuropathic Pain via the TRPV1-Mediated CaMKII/CREB Pathway in Rats.

Zheng Y, Li S, Kang Y, Hu Q, Zheng Y, Wang X J Mol Neurosci. 2024; 74(3):79.

PMID: 39162890 DOI: 10.1007/s12031-024-02256-w.


Comparison of the efficiencies of intrathecal and intraganglionic injections in mouse dorsal root ganglion.

Aydin M, Yigit E Turk J Med Sci. 2024; 53(5):1358-1366.

PMID: 38813001 PMC: 10763772. DOI: 10.55730/1300-0144.5702.


CDDO regulates central and peripheral sensitization to attenuate post-herpetic neuralgia by targeting TRPV1/PKC-δ/p-Akt signals.

Lu C, Lin C, Lu Y, Tsai H, Lin C, Wu C J Cell Mol Med. 2024; 28(6):e18131.

PMID: 38426931 PMC: 10906387. DOI: 10.1111/jcmm.18131.


Resiniferatoxin: Nature's Precision Medicine to Silence TRPV1-Positive Afferents.

Szallasi A Int J Mol Sci. 2023; 24(20).

PMID: 37894723 PMC: 10606200. DOI: 10.3390/ijms242015042.


References
1.
Lindenlaub T, Teuteberg P, Hartung T, Sommer C . Effects of neutralizing antibodies to TNF-alpha on pain-related behavior and nerve regeneration in mice with chronic constriction injury. Brain Res. 2000; 866(1-2):15-22. DOI: 10.1016/s0006-8993(00)02190-9. View

2.
Karai L, Brown D, Mannes A, Connelly S, Brown J, Gandal M . Deletion of vanilloid receptor 1-expressing primary afferent neurons for pain control. J Clin Invest. 2004; 113(9):1344-52. PMC: 398431. DOI: 10.1172/JCI20449. View

3.
Hensellek S, Brell P, Schaible H, Brauer R, Segond von Banchet G . The cytokine TNFalpha increases the proportion of DRG neurones expressing the TRPV1 receptor via the TNFR1 receptor and ERK activation. Mol Cell Neurosci. 2007; 36(3):381-91. DOI: 10.1016/j.mcn.2007.07.010. View

4.
Chaplan S, Bach F, Pogrel J, Chung J, Yaksh T . Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods. 1994; 53(1):55-63. DOI: 10.1016/0165-0270(94)90144-9. View

5.
Reeve A, Patel S, Fox A, Walker K, Urban L . Intrathecally administered endotoxin or cytokines produce allodynia, hyperalgesia and changes in spinal cord neuronal responses to nociceptive stimuli in the rat. Eur J Pain. 2000; 4(3):247-57. DOI: 10.1053/eujp.2000.0177. View